SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-076244
Filing Date
2024-06-21
Accepted
2024-06-21 16:15:03
Documents
2
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1558
2 EX-24 omga-ex24.htm EX-24 15120
  Complete submission text file 0000950170-24-076244.txt   18141
Mailing Address C/O MERCK & CO., INC. ONE MERCK DRIVE, WS2A-40 WHITEHOUSE STATION NJ 08889
Business Address
Kender Richard N (Reporting) CIK: 0001381205 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40657 | Film No.: 241060339

Mailing Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141
Business Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141 (617) 949-4360
Omega Therapeutics, Inc. (Issuer) CIK: 0001850838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)